Prostate Cancer Patient Voices
Prostate Cancer Patient Voices
  • Patient Journeys
  • Elevated PSA
    • Elevated PSA
    • Changes in PSA
    • Risk Factors
  • Diagnosis
    • Understanding Your Results
    • Treatments
    • Recurrence
    • Progression
  • Life Beyond Diagnosis
    • Coping with Side Effects
    • Mental Health
    • Sexual Health
    • Incontinence
    • Physical Health
  • Clinical Trials
    • What Is a Clinical Trial?
    • When to Consider?
    • Common Myths
    • Finding a Trial
  • Resources
    • Veterans Support
    • Health Equity
    • Conference Highlights
    • Patient Advocacy
    • Patient Journal Club
    • FAQ
    • Glossary of Terms
Cancer Patient Voices
  • Patient Journeys
  • Elevated PSA
    • Elevated PSA
    • Changes in PSA
    • Risk Factors
    Lauren Engel, NP on Changing PSA levels

    Lauren Engle, NP

  • Diagnosis
    • Understanding Your Results
    • Treatments
    • Recurrence
    • Progression

    Shared Decision Making

  • Life Beyond Diagnosis
    • Coping with Side Effects
    • Mental Health
    • Sexual Health
    • Incontinence
    • Physical Health

    Living with PCa

  • Clinical Trials
    • What Is a Clinical Trial?
    • When to Consider?
    • Common Myths
    • Finding a Trial

    Understanding Clinical Trials

    Understanding Clinical Trials

     

  • Resources
    • Veterans Support
    • Health Equity
    • Conference Highlights
    • Patient Advocacy
    • Patient Journal Club
    • FAQ
    • Glossary of Terms

    Caregiver Support

Back to Patient Journeys

In Conversation: Dr. Alicia Morgans and Brian Bernard on Navigating Clinical Trials for Advanced Prostate Cancer

Back to Patient Journeys

Brian Bernard shares his experience living with advanced prostate cancer and participating in a clinical trial with Dr. Alicia Morgans. Together, they discuss what influenced his decision, the importance of understanding treatment options, and how a supportive care team can help patients navigate clinical trials.

 

Alicia Morgans:

Hi, my name is Alicia Morgans and I'm a GU medical oncologist at Dana-Farber Cancer Institute in Boston. I'm so excited to be here today with Mr. Brian Bernard, and we're talking about clinical trials and how important they are. Thank you so much for being here with me today, Brian.

Brian Bernard:

Thanks for having me. Appreciate it.

Alicia Morgans:

Wonderful. So Brian, can you set the stage a little bit and tell people about your prostate cancer diagnosis? Where are you in this experience?

Brian Bernard:

I got diagnosed back in May of 2020, right after COVID hit. It was about seven weeks after COVID hit. So I got to go to the emergency room and get seen right away. And I actually thought I had kidney stones. I had these really sharp pains in my groin and I thought I was experiencing kidney stones. I was like, "Oh, god, I hope I don't have kidney stones." And I went to the hospital and they checked me and they said, "Not kidney stones. You got cancer and we operate tomorrow." And I was just left there by myself with no one to talk to. It was just really, really devastating. And I had to sit there and process that for a little while until I started calling family and explaining what's going on. And then they came to the hospital the next day and stuff. So it was an eye-opener for sure. It's a thing you never want to hear from a doctor.

So then they did the operation and they came back... And first he thought I had bladder cancer and he said, "You have about three to six weeks to live, get your affairs in order." And that was a real shocker. And then they did the operation and realized that it was just a stage four prostate cancer and I have about two to three years to live. So he said, "Good news, bad news." And the bad news was I only had two to three years.

And now it's six years and five months next Friday. So I proved them wrong, I proved them wrong that I can survive this. And a lot of it has to do with my spirit, I think, and just wanting to live longer. I have a son that's 22 and in college and an ex-wife that I still care a lot about. And I really wanted to still be there for them and see moments in their lives.

So I just kept doing everything they told me to do. The first year I went to Memorial Sloan Kettering Center, and they're wonderful there. They did some genetic testing, they found out I was born with the gene in my spine. And then they put me on hormonal therapy.

So my cancer started to spread back in May of this year. And so they took me off the Zytiga and they wanted me to sign up for a new clinical trial with Janssen Pharmaceuticals called Pasritamig. It's a new drug called Pasritamig, it's supposed to help build your immune system up. So they started me on that on July 27th and I did three rounds of infusions of the Pasritamig. And I've done three rounds of chemo on top of that, sometimes with it and sometimes without it.

But during this whole process, I mean, I've lost a lot of things in my life personally. I had a nice apartment I've had for 15 years, that went away. I couldn't afford to pay rent there anymore, so I had to get out of there. I lost my career. But when he told me about the new clinical trial and that could possibly prolong my life and feel better about myself, I signed up immediately. And they said only 800 people got elected to do this and I'm only like 364 patients, and this is worldwide. So it's like winning the lottery doing this. But one of the doctors here, one of the big doctors here, told me that the drug is really, really good and it's really helping a lot of people.

Alicia Morgans:

Yeah.

Brian Bernard:

And that just gave me such a boost today. You have no idea how good I felt when he told me that.

Alicia Morgans:

So I wanted to talk with you a little bit about clinical trials, which can be really scary for people to think about, and challenging, especially if people think about instances where they feel like people were experimented on or bad things were happening on clinical trials. And that's not the way trials are today and that's not the way trials are run. But I think it's important for people to hear that from a person who is on a clinical trial. What made you think about doing a clinical trial and how did you make that choice?

Brian Bernard:

When I first went to Memorial Sloan, with the first cancer center I joined when I first got sick, they told me because they started me on the hormonal drug right away that they couldn't do any clinical trials on me because I already started treatment.

Alicia Morgans:

Yes.

Brian Bernard:

So I was like, "Oh, man," because I heard good things about clinical trials, "I know sometimes it's a shot of the dice, but they're trying here." And so when I found that out and then when they offered it to me here just back in May or so, they approached me with it. I said, "Of course." I mean, if anything, it's going to teach somebody something. Even if people give it that stigma, "You're a guinea pig now." "No, I'm not. I'm just another person, sick, and they're going to try something that may help me. And if it doesn't, it doesn't."

And one person did ask me, "Is it a placebo effect?" I know some people do that as a placebo thing to see if it's real or not. But no, when they told me all about it and they gave me a packet about this thing to read, and I literally read every page. And when I went and talked back with the team of researchers, clinical nurses and doctors, I had a series of questions and they could tell I read the packet. You know what I mean? And they were so happy that I was actually got involved and really wanted to learn about the clinical trial. And they told me, really, they think it would be really beneficial for me. And I was like, "Let's go. Let's start this tomorrow if you want." You know what I mean? I was ready to go. But I had to do a washout period.

Alicia Morgans:

Yeah. And this can be common with a clinical trial. You have to come off of one therapy and have that sort of no treatment for a very brief period of time before they start something new.

Brian Bernard:

Right.

Alicia Morgans:

We wouldn't want an interaction. And that's going to vary for each trial. But importantly, that's going to be something that they talk about both in that big packet, that consent document, but also the whole team that comes with a clinical trial talks to you about it. And like you said, they were really enthusiastic.

Can you tell us a little bit about that team, about the army that helps to take care of somebody who participates in a clinical trial? Which is not just the doctor.

Brian Bernard:

No, no, of course not. Geez, I got a stack of cards and all. I got a social worker now, she's wonderful. I have this one lady, Alicia, she comes in, they do a survey for me every time I do my infusions. She sits with me for about an hour, and we do this thing on an iPad, and we answer all the questions of how I feel this week, and what my pain level might be, and what symptoms I may have. And it's just all standard question stuff, a questionnaire thing. But they all pull together. They come in one after another, after another. And I'm like, "Man, how many people are you?" It's incredible how they all work well together. And they even bring a dog around that comes and-

Alicia Morgans:

Oh, a therapy dog too.

Brian Bernard:

... they let you pet the dog.

Alicia Morgans:

No, that's really nice.

Brian Bernard:

Yeah, a support dog. I think it's pretty cool that they bring them in every Monday. Sally, her name is Sally. She's so sweet.

Alicia Morgans:

That's great. Well, I wish every clinical trial had a Sally.

Brian Bernard:

Yeah.

Alicia Morgans:

A support dog would be nice.

Brian Bernard:

It's really cool how they all come together and they all stay together with... They all linked each other, we're all linked in each email.

Alicia Morgans:

That's great.

Brian Bernard:

It's wonderful. Yeah, it's really helpful.

Alicia Morgans:

A lot of times those teams include additional social workers, research coordinators that come in and ask you to do-

Brian Bernard:

Right. A therapist is involved.

Alicia Morgans:

Therapists.

Brian Bernard:

Yeah. Yeah.

Alicia Morgans:

Research nurses, of course the doctor, maybe a nurse practitioner, a physician's assistant, and they have the staffing and resources to engage and be even more responsive sometimes-

Brian Bernard:

Of course, yeah.

Alicia Morgans:

... than they can be through the portal in other ways. So that's fantastic. And I love that the team even includes Sally.

Brian Bernard:

Yeah.

Alicia Morgans:

So that is great.

Brian Bernard:

Yeah. And they work well with my oncologist and he usually has a nurse or two there too. So when they come in, they kind of all interview me at the same time.

Alicia Morgans:

Great. Great.

Brian Bernard:

They basically all answer questions together.

Alicia Morgans:

So how did you make the decision to participate in a clinical trial?

Brian Bernard:

Well, first it was highly suggested by my oncologist. He thought that, I guess he must've heard of this new drug that's out, and he suggested that definitely should be something I would consider. And I discussed it... My son's in college and he wants to be a neurologist or in neuroscience. So he knows a few things. So I discussed it with him. He goes, "Dad, if they offer you anything clinical trial, you take it, you take it. They're really learning a lot of stuff, man. And the research is incredible lately." And just by listening upstairs before to one of the main speakers, they were talking about how many men have survived this year because of the research they've done, which is amazing.

It's really prolonging... They told me in the beginning that if you ever get cancer the best one to get is prostate, because you could live the longest on prostate. That's what I've been told. And it turns out that is true.

Alicia Morgans:

Well, tell me, do you feel like it was a good decision to do this clinical trial?

Brian Bernard:

I think it was a great decision. It was a no-brainer for me. I did discuss it with my ex-wife. I did discuss it with my niece and her husband because they're a big part of my life, and my son, and my doctor. And they just thought, I mean, it was almost like, "What do you got to lose?" Kind of a thing. "You're starting to spread again, so I know they were going to knock it out with the chemo," because my tumor was nine centimeters, now it's only four and a half, two months later. So it's getting down.

Alicia Morgans:

That's great.

Brian Bernard:

So it's just a matter of, it was an easy decision to make. It really wasn't that difficult. It was getting elected was the part that I was a little worried about because they said, "They're just going to submit my information and hopefully they accept you."

Alicia Morgans:

So being eligible, meeting all of those criteria, that can be harder.

Brian Bernard:

Yeah.

Alicia Morgans:

And the other thing that people think about that I just want to mention before we start to wrap up is that you have to be eligible, you have to be interested, and it's important to read that consent document that you talked about that helps the person understand, "Am I getting standard treatment plus something? Or is there a placebo involved? Or what does that trial scheme look like?" And for an individual person, they may be interested in engaging or not engaging, but asking the question, finding out what's available, and understanding what trials are out there is absolutely the first step.

Brian Bernard:

Absolutely.

Alicia Morgans:

And I love that you're sharing that. Well, what would your advice be to someone who's facing prostate cancer and is thinking about, "Should I do a clinical trial or shouldn't I?" What would your advice be?

Brian Bernard:

What do you got to lose? I mean, I highly, highly, highly recommend it. I really do. I think the people out there that are learning about this disease and just listening to everybody speak today, it's just amazing how much information is out there. And I just think it'll do anything but benefit you, if anything. And if you have side effects, they'll stop it right away. You know what I mean?

But with these new clinical trial drugs, I mean, honestly, since I've been taking Pasritamig, I feel a little more energetic, even though I get fatigue and everything, but for the first few days I feel pretty good. And I got a great appetite, which is very odd because I thought if you take chemo you don't eat. You just sit there and wither away and you get under a blanket and you just look sick. And it's actually given me a good appetite and everything, which is really surprising. That was a big surprise to me.

Alicia Morgans:

I wish you nothing but success as you move forward and all of the success in this clinical trial. And I thank you so much for sharing your thought process and thank you for your time today.

Brian Bernard:

Thank you, Alicia. Appreciate it. Thank you.

Editor's note: This video reflects the speaker’s personal experience and is not medical advice. Talk with your healthcare team about your care.

 

This interview was produced with the generous support of AstraZeneca Pharmaceuticals

Stay informed.
Be inspired and empowered.
Join our community today!

Sign Up

Contact

UroToday/Digital Science Press, LLC.

5725 S. Valley View Blvd., Suite 5
PMB 733914
Las Vegas, NV 89118

Visit Website

Email Us

  • Who We Are
  • About Us
  • UroToday
  • Medical Editors
  • Prostate Cancer Foundation

Follow Us

Bayer Logo

This website is supported through an unrestricted educational grant from Bayer. Bayer is not involved in content development and the views expressed represent those of the patient and physician contributors.

© Copyright 2026. Prostate Cancer Patient Voices. All rights reserved.

Press Release

Privacy Policy

Terms of Use